Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ALFANAPRAPATEN AS
AS
Active
Org 922737223
Strømsveien 24E, 0658
Oslo
Traditional, complementary and alternative medicine activities
· NACE 8696
Est. 2019
1 employees
Watchlist
Share
Norway
/
Companies
/
Traditional, complementary and alternative medicine activities
/
ALFANAPRAPATEN AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
662
680
1 030
1 011
831
Staff expenses
−423
−347
−435
−0
−647
EBITDA
−15
106
299
153
16
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−15
106
299
153
16
Net financials
−3
22
2
−1
0
Profit before tax
−18
129
301
152
16
Tax
−0
−0
61
−0
−0
Net profit
−18
129
240
52
16
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
590
614
829
954
1 034
Equity
510
542
773
834
825
Long-term debt
10
0
0
0
0
Short-term debt
69
72
56
120
209
Total debt
80
72
56
120
209
Financial ratios
5-year trend
EBITDA margin
2.0%
This company
15.8%
Market median
-87% vs market
2021
2025
Equity ratio
79.8%
This company
38.2%
Market median
+109% vs market
2021
2025
Return on equity
2.0%
This company
18.4%
Market median
-89% vs market
2021
2025
Net profit margin
2.0%
This company
8.1%
Market median
-75% vs market
2021
2025
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
2021
2025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on ALFANAPRAPATEN AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network